2013 was a year of significant growth for ISIS Pharmaceuticals, Inc. (NASDAQ:ISIS) with successes in every aspect of our business. KYNAMRO® is the first systemic antisense drug for chronic use to be sold commercially. ISIS Pharmaceuticals, Inc. (NASDAQ:ISIS) stock opened at $57.03 in last session, and closed at $51.00, while the day range of ISIS Pharmaceuticals, Inc. (NASDAQ:ISIS) stock is $48.51 – $58.31. The stock showed a positive weekly performance of -13.56%.
ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) posted its quarterly earnings results on Thursday. The company reported ($0.13) earnings per share for the quarter, beating the analysts’ consensus estimate of ($0.14) by $0.01, Stock Ratings News reports. ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) stock opened at $29.20 in last session, and closed at $28.30 by losing -5.98%. The 52 week range of $6.02 – $32.00. Company’s market capitalization is $2.53B.
Zulily Inc. (NASDAQ:ZU) and LinkedIn Corp. helped drive gains in the tech sector as investor’s embraced good news from both companies. Zulily Inc. (NASDAQ:ZU) stock decreased -5.99% and finished the last session at $68.39. The EPS of the stock remained -0.28. Company’s market capitalization is $8.35B.
RetailMeNot Inc. (NASDAQ:SALE) is the world’s biggest digital coupon marketplace. It aggregates digital coupons and promotes sales from retailers across many product categories from clothing and electronics to health and beauty. In 2013, the company featured digital coupons from 70,000 retailers and brands and had 550 million total visits to its websites. RetailMeNot Inc. (NASDAQ:SALE) stock opened the session at $47.16, and closed the session at $41.77. The 52 week range of the RetailMeNot Inc. (NASDAQ:SALE) stock remained $25.51 – $48.73 and the day range was $39.63 – $48.30.
Leave a Reply